|
Mark Ahn, President & CEO of Hana Biosciences, Inc., Presides Over the Market Close |
| |

Mark Ahn, President & CEO of Hana Biosciences, Inc., rings The NASDAQ Stock Market Closing Bell |
Mark Ahn, President & CEO of Hana Biosciences, Inc., Rings The NASDAQ Stock Market Closing Bell
Thursday, June 29, 2006
at NASDAQ's MarketSite
in New York City.

Hana Biosciences, Inc. |
| |
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote
Mark Ahn, President & CEO of Hana Biosciences, Inc. (HNAB) presides over the closing bell to celebrate its start of trading on NASDAQ.
Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.
Reprints
|